Amgen

Avsola - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5121

HCPCS Code Descriptor:

Injection, infliximab-axxq, biosimilar, (avsola), 10 mg

Medicare Payment Limit:

The Avsola Medicare Payment Limit is $24.373

Average Sale Price:

Avsola ASP cost available once logged in. Avsola is a biosimilar drug making the ASP calculation more complex. Avsola's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The Avsola Medicare Co-insurance percentage is 20%. Avsola's Medicare Co-insurance amount is $4.87 per HCPCS unit.

APC Code:

The Avsola APC Code is: 9381

APC Payment Limit:

The APC Payment Limit for Avsola is available. Login to view.

Avsola Cost Information:

Avsola (Q5121) is an infliximab biosimilar to the reference product Remicade (J1745). Avsola’s HCPCS became effective in July of 2020 and the average sales price was first published in October of 2020. Avsola’s WAC/AWP pricing has remained steady since launch while it’s ASP has steadily declined. This is likely due to price competition between other biosimilars in the infliximab space.

ACCESS PRICING AND MORE BY REGISTERING

Avsola’s wholesale acquisition cost (WAC) information was last updated on:
May 26, 2020
Avsola’s average wholesale price (AWP) information was last updated on:
May 26, 2020